Literature DB >> 7913919

Sulphasalazine desensitisation in patients with arthritis.

C McCarthy1, R Coughlan.   

Abstract

Skin rash is a common side effect of sulphasalazine. Desensitisation, with a gradual introduction of the drug, may prevent rash. This study reports a 33% (3/9 patients) success rate of desensitisation in patients with arthritis. Desensitisation should only be attempted if sulphasalazine has been efficacious in treating the joint symptoms.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7913919     DOI： 10.1007/bf02943259

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  11 in total

1.  The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensibilization in cases of hypersensitiveness to sulfa.

Authors:  M SVARTZ
Journal:  Acta Med Scand       Date:  1948

2.  Desensitisation to allopurinol.

Authors:  S M Kelsey; G R Struthers; T Beswick; D R Blake
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

3.  Specific hyposensitization of patients with penicillin allergy.

Authors:  J Pedersen-Bjergaard
Journal:  Acta Allergol       Date:  1969-11

4.  Sulphasalazine desensitisation in rheumatoid arthritis.

Authors:  M Farr; D L Scott; P A Bacon
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

5.  Sulphasalazine desensitisation.

Authors:  C D Holdsworth
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

6.  Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.

Authors:  M Farr; P A Bacon
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

7.  Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.

Authors:  D E Bax; R S Amos
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

8.  Desensitization to sulphasalazine in patients with arthritis.

Authors:  J M Koski
Journal:  Clin Exp Rheumatol       Date:  1993 Mar-Apr       Impact factor: 4.473

9.  Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial.

Authors:  R S Pinals; S B Kaplan; J G Lawson; B Hepburn
Journal:  Arthritis Rheum       Date:  1986-12

10.  Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

Authors:  R S Amos; T Pullar; D E Bax; D Situnayake; H A Capell; B McConkey
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.